生物製藥物流市場報告：2030 年趨勢、預測與競爭分析

生物製藥物流趨勢及預測

預計到 2030 年，全球生物製藥物流市場將達到 1,292 億美元，2024 年至 2030 年複合年成長率為 7.5%。該市場的主要驅動力是精準醫療和基因治療的興起、家庭醫療用品需求的成長以及外包物流業務的成長趨勢。全球生物製藥物流市場的未來前景廣闊，製藥、生物製藥、藥局、醫院、診所和超級市場市場都有機遇。

Lucintel預測，由於對溫控產品的需求不斷增加以及需要精確的溫控物流服務以確保產品有效性，低溫運輸物流將在預測期內出現高速成長。

在這個市場中，預計藥品在預測期內將出現最高成長。

由於該地區醫藥產品進出口不斷擴大，預計北美在預測期內仍將是最大的地區。

生物醫學流市場新趨勢

改變市場需求的新興技術正在推動生物製藥物流市場提高效率、合規性和服務品質的主要趨勢。與此主張相關的一些最常見的趨勢包括：

• 先進的低溫運輸技術：我們開發了先進的低溫運輸低溫運輸，包括物聯網感測器和自動溫度控制系統，以增強我們在整個供應鏈中維持嚴格溫度要求的能力。它還確保對溫度敏感的生物製藥的完整性和有效性，減少變質的機會，並有助於滿足監管標準。
• 整合區塊鏈技術：生物製藥物流正在尋求以提高可追溯性和完全透明度的方式整合區塊鏈技術。區塊鏈描述了交易和產品移動的永久記錄。區塊鏈可以防止假冒，提高記錄的準確性，確保生物製藥產品整個供應鏈的真實性和安全性。人工智慧和自動化的應用現代人工智慧擴大應用於物流和營運的最佳化，例如庫存管理、路線規劃和預測性維護。人工智慧和自動化提高了交付計劃的可靠性，同時提高了業務效率，減少了人為錯誤，並增強了決策以降低成本。
• 生物製藥電子商務的成長：電子商務的成長開始影響生物製藥物流。這一趨勢要求物流和供應商適應新的交付方式，包括最後一哩交付解決方案，並實施能夠解決直接向患者交付的獨特挑戰的系統。
• 加強監管合規性：高度重視確保完全遵守各個地區嚴格的監管標準，例如溫度控制、文件記錄和報告要求。監管合規性的提高導致了更複雜的物流解決方案的發展，需要更詳細的文件並符合國際標準，以確保生物製藥的安全和品質。
• 這些趨勢使供應鏈更加有效、透明且符合法規，從而顯著改變了生物製藥物流市場格局。隨著技術發展的不斷進步，這些新趨勢將進一步擴大行業內的創新和適應範圍，以滿足世界對生物製藥不斷變化的需求。
• 生物醫學流市場近期趨勢
• 生物製藥物流市場的最新趨勢是由技術進步、監管變化和不斷變化的行業需求所驅動的。
• 低溫運輸創新：低溫運輸技術的顯著增強，例如先進的溫控包裝和基於物聯網的監控系統，使生物製藥物流服務更加可靠。這些創新確保對溫度敏感的產品在最佳條件下得到維護和運輸，以保持其完整性，最大限度地減少損壞和合規問題。
• 數位化和即時追蹤：物流領域正在逐漸轉變為數位工具和即時追蹤系統的世界。 RFID 和 GPS 是用於追蹤貨物位置和狀況的一些技術。即時追蹤提高了供應鏈的可視性，並能夠及時干預和管理預期的中斷。
• 擴大物流網路：物流網路正在擴大，轉向建立新的物流中心和發展更好的交通基礎設施。擴大網路的優勢在於，可以確保更快分配產品的效率，以滿足全球經濟對產品的需求。
• 採用人工智慧和機器學習：人工智慧和機器學習技術的應用可以最佳化物流業務，例如需求預測、路線最佳化和庫存管理。這些技術有助於提高業務效率、降低成本並提高物流和流程管理的準確性。
• 監管適應：生物製藥物流的新挑戰是改善溫度控制和文件管理的法律規範的核心。監管調整旨在確保更高水準的安全和品質標準並開發更先進的物流解決方案。
• 這些趨勢對提高生物製藥物流市場的業務效率、合規性和整體服務品質做出了重大貢獻。這些新興市場的開拓預計將支持生物製藥產業的新需求，並為該市場的物流業務帶來更高的可靠性。
• 生物醫學流市場的策略性成長機會
• 生物製藥物流市場透過多種不同的應用提供了各種策略性成長機會，顯示對先進物流解決方案和技術創新的需求不斷成長。
• 低溫運輸管理：投資先進的低溫運輸管理解決方案帶來了巨大的成長機會。主動冷卻系統和即時監控等技術可以確保溫度敏感產品的完整性。改進的低溫運輸管理有助於確保藥品保持在非常窄的溫度範圍內，同時最大限度地減少廢棄物，以滿足對生技藥品和個人化醫療不斷成長的需求。
• 電子商務和直接面向患者的運輸：電子商務和直接面向患者模式的成長趨勢正在為專業物流提供者創造新的機會。開發高效的最後一哩交付解決方案，以跟上家庭護理趨勢。這個不斷成長的市場需要便利性和直接的交付選擇。這些選項需要能夠處理複雜的交付要求和患者互動的物流解決方案。
• 高階資料分析：在物流業務中利用高階資料分析的力量是一個明顯的成長機會。分析透過更好地進行需求預測、路線規劃甚至庫存管理來進一步最佳化物流業務。提高資料分析能力將帶來更有效率的物流業務、減少浪費費用和更好的決策，推動整個生物製藥產業的成長。
• 自動化和機器人技術：透過將自動化和機器人技術引入物流業務，可以實現更大的成長空間。倉儲、分類和運輸的自動化系統變得更有效率和準確。自動化對於企業來說是一項有前途的投資，可以確保平穩營運，因為它可以透過減少人為錯誤來降低營運成本並提高物流流程的速度。
• 監管合規解決方案：確保您擁有符合不斷發展的監管標準的解決方案，為成長掃清道路。這包括透過技術追蹤、報告和維護品質標準。合規解決方案可協助物流提供者滿足嚴格的法規，同時降低與違規相關的風險，並確保生物製藥交付的安全性和生產力。
• 這些新的成長機會將決定生物製藥物流市場的未來方向，無論是透過識別和開拓新需求還是透過技術進步。隨著市場的發展，這些新機會將推動生物製藥物流的創新和可靠性提高效率。
• 生物醫學流市場推動因素及挑戰
• 有許多技術、經濟和監管因素正在推動生物製藥物流市場的成長，同時也帶來了重大挑戰。主要促進因素包括技術進步和對生物製藥的需求增加，而高昂的實施成本、資料安全和複雜的監管合規性是顯著的挑戰。了解這些動態將有助於相關人員有效地穿越市場、利用機會並克服障礙。
• 推動生物製藥物流市場的因素包括：

1. 技術進步：物聯網、人工智慧和區塊鏈是正在徹底改變生物製藥物流領域的一些更廣泛的技術。物聯網感測器更準確、即時地監測溫度，人工智慧最佳化路線規劃和庫存管理，區塊鏈使鏈條中的每個環節高度透明且可追溯。這些增強功能提高了效率，減少了出錯的可能性，並提高了對溫度敏感的貨物的完整性。因此，它滿足了對更複雜的物流解決方案的需求，最終有助於使供應鏈更加可靠和有效率。

2. 生物製藥的需求增加：顯然，醫學研究的進步、慢性病盛行率的上升以及世界人口的老化將增加對生物製藥（例如生技藥品和個人化藥物）的需求。相應地，更多的高價值產品需要更專業的物流來管理複雜的供應鏈。

3. 擴大全球供應鏈的好處：供應鏈的全球化產生了對強大的生物製藥物流解決方案的需求。隨著公司拓展國際市場，他們需要一個能夠管理跨境運輸並確保滿足各種監管標準的物流網路。高效的全球物流解決方案可實現及時交付並減少中斷。這對於保持生物製藥產品平臺暢通並滿足全球客戶群的要求是必要的。

• 生物製藥物流市場的挑戰包括：

1.技術實施成本高：物聯網系統、區塊鏈等先進技術的實施成本極高。成本包括一次性技術投資、持續維護以及與現有系統的整合。這些可能成為小型物流企業的進入障礙，而且成本可能非常高，限制了他們提供高科技解決方案的潛力。這可能會導致大小市場參與企業之間出現數位落差。

2.資料隱私和安全問題：生物製藥物流的主要挑戰之一是如何保護敏感的醫療資訊。確保資料隱私和安全需要採取適當的網路安全措施並遵守 GDPR 和 HIPAA 等各種法規。資料外洩和安全故障可能導致法律糾紛、失去信任和罰款。解決這些問題需要對安全技術和流程進行大量投資。

3. 監管合規的複雜性：不同的區域法規環境對生物製藥公司的物流提供者構成了真正的挑戰。有關處理、文件和運輸的規定可能因國家而異。遵守所有相關法規需要大量的知識和資源。違規可能導致延誤、罰款和市場進入問題。

• 生物製藥物流市場的關鍵促進因素包括技術發展、不斷成長的需求和監管要求，而業務效率和全球供應鏈提供了顯著的好處。然而，高昂的實施成本、資料安全問題和複雜的監管合規問題是該市場的缺點。平衡這些市場促進因素和挑戰是相關人員順應市場發展並利用成長和創新機會的關鍵。
• 生醫藥流企業名錄
• 市場上的公司透過其提供的產品品質進行競爭。該市場的主要企業專注於擴大製造設施、投資研發、開拓基礎設施以及利用整個價值鏈的整合機會。透過這些策略，生物製藥物流公司正在滿足不斷成長的需求、確保競爭、開發創新產品和技術、降低製造成本並擴大基本客群。本報告介紹的生物醫學流企業如下。
• Kuehne+Nagel
• CH Robinson
• United Parcel Service
• Deutsche Post DHL
• Panalpina World Transport

目錄

第1章執行摘要

第2章 全球生物醫學流市場：市場動態

• 簡介、背景、分類
• 供應鏈
• 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

• 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
• 全球生物製藥物流市場趨勢（2018-2023）與預測（2024-2030）
• 按產品類型分類的全球生物製藥物流市場
  • 低溫運輸物流
  • 非低溫運輸物流
• 按運輸服務類型分類的全球生物製藥物流市場
  • 運輸
  • 倉儲和儲存
• 全球生物製藥物流市場（依最終用途）
  • 藥品
  • 生物製藥
  • 藥局
  • 醫院
  • 診所
  • 超級市場
  • 其他

第4章 2018-2030年區域市場趨勢及預測分析

• 生物醫學流市場區域分佈
• 北美生物醫學流市場
• 歐洲生物醫學藥物流市場
• 亞太生物醫藥物流市場
• 其他地區生物醫學藥物流市場

第5章 競爭分析

• 產品系列分析
• 業務整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 按產品類型分類的全球生物製藥物流市場成長機會
  • 按運輸服務類型分類的全球生物製藥物流市場成長機會
  • 全球生物製藥物流市場最終用途的成長機會
  • 全球生物製藥物流市場按地區成長機會
• 全球生物醫學流市場新趨勢
• 戰略分析
  • 新產品開發
  • 擴大全球生物製藥物流市場的能力
  • 全球生物醫藥物流市場的合併、收購與合資
  • 認證和許可

第7章主要企業概況

• Kuehne+Nagel
• CH Robinson
• United Parcel Service
• Deutsche Post DHL
• Panalpina World Transport

Biopharmaceutical Logistic Trends and Forecast

The future of the global biopharmaceutical logistic market looks promising with opportunities in the pharmaceutical, biopharmaceutical, pharmacy, hospital, clinic, and supermarket markets. The global biopharmaceutical logistic market is expected to reach an estimated $129.2 billion by 2030 with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are rising number of precision medicines and gene therapies, growing demand for household healthcare items, and augmenting trend of outsourcing logistical operations.

Lucintel forecasts that cold chain logistic is expected to witness the higher growth over the forecast period due to its increasing need for temperature-controlled products, necessitating precise temperature control logistics services to ensure the efficacy of the goods.

Within this market, pharmaceutical is expected to witness the highest growth over the forecast period.

North America will remain the largest region over the forecast period due to expanding number of pharmaceuticals export and importation activity in the region.

Emerging Trends in the Biopharmaceutical Logistic Market

The advanced technologies that have caused a change in the landscape of market needs have driven the key trends of improving efficiency, compliance, and service quality in the biopharmaceutical logistics market. Some of the most prevailing observed trends in relation to the said proposition include:

• Advanced Cold Chain Technologies : Advanced cold chain technologies are being developed-including IoT sensors and automated temperature control systems-that enhance the capability to maintain strict temperature requirements through the supply chain. Besides, it ensures the integrity and effectiveness of temperature-sensitive biopharmaceutical products, lessening the potential for spoilage and making sure that they are able to conform to regulatory authority standards.
• Integration of Blockchain Technology: Biopharmaceutical logistics is going to integrate blockchain technology in ways that enhance traceability and total transparency. It provides a permanent record of transactions and product movements. Blockchain prevents counterfeits, improves record accuracy, and guarantees the authenticity and safety of a biopharmaceutical product through the supply chain. The applications of AI and Automation Description: Artificial Intelligence in recent times is finding its applications increasingly in optimizing logistics operation-inventory management, route planning, predictive maintenance. Artificial intelligence and automation raise operational efficiency, reduce human errors, and enhance decision-making for cost savings, while the reliability of delivery schedules is improved.
• Growth of E-commerce in Biopharma: Growth in e-commerce has begun to impact how the logistics of biopharmaceuticals work, particularly with regard to an increased demand for direct-to-patient delivery models and home-based treatments. The trend requires the adaptation of logistics providers to new methods of delivery, including last-mile delivery solutions, and to implement systems that can handle the unique challenges of direct-to-patient shipments.
• Increased Regulatory Compliance: High attention is being paid to making sure there is complete compliance with strict regulatory standards in various regions, including requirements in regard to temperature control, documentation, and reporting. Better regulatory compliance leads to the evolution of more complex logistics solutions, requiring more detailed documentation and compliance with international standards that ensure the safety and quality of biopharmaceutical products.
• These trends are restructuring the outlook of the biopharmaceutical logistics market by making supply chains more effective, transparent, and regulatory compliant. As technological development continues to keep pace, these emerging trends will further extend the area of innovation and adaptation within the industry as it meets the continuously changing needs around the world for biopharmaceuticals.
• Recent Developments in the Biopharmaceutical Logistic Market
• Recent developments in the biopharmaceutical logistics market are powered by technological advances, changes in regulations, and changing industrial needs.
• Cold Chain Innovation: There is great enhancement in cold chain technology, such as advanced temperature-controlled packaging and IoT-based monitoring systems, that raise the bar for the dependability of logistics services for biopharmaceuticals. These innovations ensure that temperature-sensitive products are maintained and transported under conditions optimal for preserving their integrity, thereby minimizing spoilage and compliance issues.
• Digitalization and Real-Time Tracking: The face of logistics is gradually metamorphosing into a world of digital tools and real-time tracking systems. RFID and GPS are some of the technologies being implemented to track both the location and condition of shipments. Real-time tracking improves supply chain visibility for timely intervention and management of expected disruptions.
• Expansion of Logistics Networks: Logistics networks are expanding, and there is a shift toward setting up new distribution centers and developing better transportation infrastructure. The advantages of extended networks are that it ensures the efficiency of distributing the products at a faster pace to meet the demand of the product in the global economy.
• Adoption of AI and Machine Learning: AI and machine learning technologies are being adopted in ways that enable the logistics operations to be optimized, including demand forecasting, route optimization, and inventory management. These technologies contribute to increased operational efficiency, cost reduction, and heightened accuracy in the management of logistics processes.
• Regulatory Adaptations: New challenges within the biopharmaceutical logistics have been the central issue for regulatory frameworks in improving controls over temperature and documentation. The adaptation to regulations aims at assuring even higher levels of safety and quality standards, developing more advanced logistics solutions.
• These trends drive a lot of improvements in operational efficiencies, compliances, and overall service quality in the biopharmaceutical logistics market. These advancement developments will support the emerging needs of the biopharmaceutical industry and provide further reliability to logistics operations in this market.
• Strategic Growth Opportunities for Biopharmaceutical Logistic Market
• The biopharmaceutical logistics market presents various strategic growth opportunities from several different applications, showcasing an increasing demand for advanced logistics solutions along with technological innovations.
• Cold Chain Management: Investment in advanced cold chain management solutions presents a significant growth opportunity. Technologies such as active cooling systems and real-time monitoring can ensure the integrity of temperature-sensitive products. Improved cold chain management helps ensure drugs remain within very narrow ranges of temperature limits, with minimization of waste to supply the rising demand for biologics and personalized medicine.
• E-commerce and Direct-to-Patient Delivery: With the increasing trend of e-commerce and direct-to-patient delivery models, new opportunities arise for specialized logistics providers. Efficient last-mile delivery solutions can be developed to help deal with the growing trend of home-based treatments. With this growth area comes demand for convenience and direct delivery options. Such an option would require logistics solutions that can handle complex delivery requirements and patient interactions.
• Advanced Data Analytics: Leveraging the power of advanced data analytics in the operations of logistics is an explicit growth opportunity. Analytics will further optimize logistics operations, as it would do a better job in demand forecasting, route planning, and even inventory management. Improved capabilities in data analytics will lead to efficient logistics operations, less wastage of money, and better decision-making, hence promoting the overall growth of the biopharmaceutical industry.
• Automation and Robotics : There is a huge scope for higher growth by introducing automation and robotics into logistics operations. Automated systems for warehousing, sorting, and transportation can be much more efficient and accurate. Automation reduces operation costs by reducing human errors and increases the speed of the logistics processes, hence becoming a promising investment to be undertaken by companies for smooth operations.
• Regulatory Compliance Solutions: Ensuring solutions that offer compliance with regulatory standards in constant evolution opens up an avenue of growth. It includes tracking, reporting, and maintaining quality standards through technology. Compliance solutions help logistics providers meet rigorous regulations while reducing risks associated with non-compliance and ensuring safety and productivity in the delivery of biopharmaceutical products.
• These emerging growth opportunities will be the future direction of the biopharmaceutical logistics market, either by identification and development of emerging needs or results through technological advancements. Innovation and further efficiency with reliability in biopharmaceutical logistics are driven by these emerging opportunities as the market is evolving.
• Biopharmaceutical Logistic Market Driver and Challenges
• Several technological, economic, and regulatory factors prevail, which drive the growth of the biopharmaceutical logistics market while presenting its significant set of challenges. Key drivers include technological advancement and increasing demand for biopharmaceuticals, while high implementation costs, data security, and complex regulatory compliance are some of the notable challenges. Being aware of these dynamics will thus be useful for the stakeholders in effectively traversing the market and leveraging opportunities to overcome obstacles.
• The factors responsible for driving the biopharmaceutical logistic market include:

1. Technological Advancement: IoT, AI, and blockchain are part of a wide range of technologies that can revolutionize the biopharmaceutical logistics sector. IoT sensors monitor temperature more precisely and in real time, while AI optimizes route planning and inventory management; blockchain makes every link in the chain highly transparent and traceable. These enhancements result in better efficiency, less chance for errors, and greater integrity of temperature-sensitive shipments. Therefore, they help to meet the demand for more sophisticated logistics solutions and, finally, make supply chains more reliable and efficient.

2. Increase in Demand for Biopharmaceuticals: The demand is evidently going to rise for biopharmaceutical products such as biologics and personalized medicines due to advancements in medical research, rising prevalence of chronic diseases, and an ageing global population. Correspondingly, there are an increasing number of high-value products requiring more specialized logistics that can manage the complexities of these supply chains, not least stringent temperature control and handling requirements.

3. The Gains from an Expanded Global Supply Chain: The globalization of supply chains has created the need for robust biopharmaceutical logistics solutions. Companies, while expanding into international markets, require logistics networks that are able to manage cross-border shipments and ensure that the variety of regulatory standards is met. Efficient global logistics solutions enable timely delivery and reduce disruptions-necessary to keep the biopharmaceutical product pipeline flowing and help meet the requirements of a worldwide customer base.

• Challenges in the biopharmaceutical logistic market are:

1. High Costs of Technology Implementation: Advanced technologies, such as IoT systems and blockchain, are very expensive to adopt. The costs include one-time technology investments, continuous maintenance, and integrations with existing systems. These could be entrance barriers and very costly for smaller logistics providers, therefore limiting their potential to provide high-tech solutions. This might lead to a certain digital divide between big and small market players.

2. Data Privacy and Security Issues: One of the major challenges in biopharmaceutical logistics is how to safeguard sensitive health information. Assuring data privacy and security requires proper cybersecurity measures and adherence to various regulations such as GDPR and HIPAA. Data breaches and security failures could result in legal disputes, a loss of trust, and fines. Addressing these issues requires heavy investment in security technologies and processes.

3. Complexity of Compliance with Authorities: The varied regulatory environments of different regions are indeed serious to work through for logistics providers catering to biopharmaceutical companies. Regulations pertaining to handling, documentation, and transportation could be different from country to country. Compliance with all relevant regulations requires enormous knowledge and resources. Noncompliance may lead to delays, fines, or problems of market access.

• Key drivers in the biopharmaceutical logistics market include technological development, growth in demand, and regulatory requirements, while operational efficiency and global supply chains significantly benefit. However, issues regarding high implementation costs, data security concerns, and complex regulatory compliance act as drawbacks to this market. The balance between such drivers and challenges is key for stakeholders to move with the evolution of the market and leverage opportunities for growth and innovation.
• List of Biopharmaceutical Logistic Companies
• Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies biopharmaceutical logistic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biopharmaceutical logistic companies profiled in this report include-
• Kuehne + Nagel
• C.H. Robinson
• United Parcel Service
• Deutsche Post DHL
• Panalpina World Transport
• Biopharmaceutical Logistic by Segment
• The study includes a forecast for the global biopharmaceutical logistic by product type, transport service type, end use, and region.

Biopharmaceutical Logistic Market by Product Type [Analysis by Value from 2018 to 2030]:

• Cold Chain Logistics
• Non-Cold Chain Logistic

Biopharmaceutical Logistic Market by Transport Service Type [Analysis by Value from 2018 to 2030]:

• Transportation
• Warehouse and Storage

Biopharmaceutical Logistic Market by End Use [Analysis by Value from 2018 to 2030]:

• Pharmaceuticals
• Biopharmaceuticals
• Pharmacies
• Hospitals
• Clinics
• Supermarkets

Biopharmaceutical Logistic Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World
• Country Wise Outlook for the Biopharmaceutical Logistic Market
• Changes in regulation, technological innovations, and shifts in global demand are some of the factors that make the pace of the biopharmaceutical logistics market very fast. This particular market niche has become pivotal for safe and timely drug delivery, as a result of the nature of most biopharmaceutical products, which are sensitive either to temperature or handling conditions. Recent developments reflect the advancement of technology, increasing demand for specialized logistics solutions, and adaptation to regulatory changes across major global markets.
• United States: In the U.S., cold chain solutions are increasingly becoming advanced, integrated with digital tracking technologies. The adoption of IoT and blockchain is improving the transparency and real-time monitoring of supply chains. Regulations are changing to aim for improved compliance with safety standards, while surging demand is noticed in logistics services due to a rise in personalized medicines and biologics.
• China: The Chinese biopharmaceutical logistics market is growing rapidly due to increased focus on healthcare modernization. Investors are building basic infrastructures like temperature-controlled warehouses and advanced logistics networks. China is still at a nascent stage in developing regulations, but its government is gradually making such legislation more stringent to ensure higher quality and safety standards, thus fostering further development in this segment with increasingly sophisticated logistics solutions.
• Germany: Automation and digitization keep pace for a better service performance in German biopharmaceutical logistics. It builds high-tech warehouses to serve the customers better and develops smart transportation solutions. The strict European Union regulations are observed on the front line, with cold-chain integrity and traceability features of biopharmaceutical products.
• India: With more emphasis on infrastructure improvement and integration of technology, the Indian biopharmaceutical logistics market is growing. Specialized logistics providers offering cold chain solutions to meet the demand at the local level continue to rise in this country. Added to that, there is pressure to develop better regulatory compliance and quality control that meets international standards in support of the rapid growth of the pharmaceutical industry.
• Japan: The integration of robotics and AI to enhance efficiency and accuracy for Japan is witnessing an upsurge in biopharmaceutical logistics. Thereby, the market bears accomplished cold chain management systems along with an elevated amount of regulatory scrutiny. Japanese logistics providers are also focused on improving their digital solutions to enable better inventory management and smoothening the supply chain.
• Features of the Global Biopharmaceutical Logistic Market
• Market Size Estimates: Biopharmaceutical logistic market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
• Segmentation Analysis: Biopharmaceutical logistic market size by product type, transport service type, end use, and region in terms of value ($B).
• Regional Analysis: Biopharmaceutical logistic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different product types, transport service types, end uses, and regions for the biopharmaceutical logistic market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biopharmaceutical logistic market.
• Analysis of competitive intensity of the industry based on Porter's Five Forces model.
• If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.
• FAQ
• Q1. What is the biopharmaceutical logistic market size?
• Answer: The global biopharmaceutical logistic market is expected to reach an estimated $129.2 billion by 2030.
• Q2. What is the growth forecast for biopharmaceutical logistic market?
• Answer: The global biopharmaceutical logistic market is expected to grow with a CAGR of 7.5% from 2024 to 2030.
• Q3. What are the major drivers influencing the growth of the biopharmaceutical logistic market?
• Answer: The major drivers for this market are rising number of precision medicines and gene therapies, growing demand for household healthcare items, and augmenting trend of outsourcing logistical operations.
• Q4. What are the major segments for biopharmaceutical logistic market?
• Answer: The future of the biopharmaceutical logistic market looks promising with opportunities in the pharmaceutical, biopharmaceutical, pharmacy, hospital, clinic, and supermarket markets.
• Q5. Who are the key biopharmaceutical logistic market companies?

Answer: Some of the key biopharmaceutical logistic companies are as follows:

• Kuehne + Nagel
• C.H. Robinson
• United Parcel Service
• Deutsche Post DHL
• Panalpina World Transport
• Q6. Which biopharmaceutical logistic market segment will be the largest in future?
• Answer: Lucintel forecasts that cold chain logistic is expected to witness the higher growth over the forecast period due to its increasing need for temperature-controlled products, necessitating precise temperature control logistics services to ensure the efficacy of the goods.
• Q7. In biopharmaceutical logistic market, which region is expected to be the largest in next 5 years?
• Answer: North America will remain the largest region over the forecast period due to expanding number of pharmaceuticals export and importation activity in the region.
• Q.8 Do we receive customization in this report?
• Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the biopharmaceutical logistic market by product type (cold chain logistics and non-cold chain logistic), transport service type (transportation and warehouse and storage), end use (pharmaceuticals, biopharmaceuticals, pharmacies, hospitals, clinics, supermarkets, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
• Market Report

Table of Contents

1. Executive Summary

2. Global Biopharmaceutical Logistic Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Biopharmaceutical Logistic Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Biopharmaceutical Logistic Market by Product Type
  • 3.3.1: Cold Chain Logistics
  • 3.3.2: Non-Cold Chain Logistic
• 3.4: Global Biopharmaceutical Logistic Market by Transport Service Type
  • 3.4.1: Transportation
  • 3.4.2: Warehouse and Storage
• 3.5: Global Biopharmaceutical Logistic Market by End Use
  • 3.5.1: Pharmaceuticals
  • 3.5.2: Biopharmaceuticals
  • 3.5.3: Pharmacies
  • 3.5.4: Hospitals
  • 3.5.5: Clinics
  • 3.5.6: Supermarkets
  • 3.5.7: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Biopharmaceutical Logistic Market by Region
• 4.2: North American Biopharmaceutical Logistic Market
  • 4.2.1: North American Biopharmaceutical Logistic Market by Product Type: Cold Chain Logistics and Non-Cold Chain Logistic
  • 4.2.2: North American Biopharmaceutical Logistic Market by End Use: Pharmaceuticals, Biopharmaceuticals, Pharmacies, Hospitals, Clinics, Supermarkets, and Others
• 4.3: European Biopharmaceutical Logistic Market
  • 4.3.1: European Biopharmaceutical Logistic Market by Product Type: Cold Chain Logistics and Non-Cold Chain Logistic
  • 4.3.2: European Biopharmaceutical Logistic Market by End Use: Pharmaceuticals, Biopharmaceuticals, Pharmacies, Hospitals, Clinics, Supermarkets, and Others
• 4.4: APAC Biopharmaceutical Logistic Market
  • 4.4.1: APAC Biopharmaceutical Logistic Market by Product Type: Cold Chain Logistics and Non-Cold Chain Logistic
  • 4.4.2: APAC Biopharmaceutical Logistic Market by End Use: Pharmaceuticals, Biopharmaceuticals, Pharmacies, Hospitals, Clinics, Supermarkets, and Others
• 4.5: ROW Biopharmaceutical Logistic Market
  • 4.5.1: ROW Biopharmaceutical Logistic Market by Product Type: Cold Chain Logistics and Non-Cold Chain Logistic
  • 4.5.2: ROW Biopharmaceutical Logistic Market by End Use: Pharmaceuticals, Biopharmaceuticals, Pharmacies, Hospitals, Clinics, Supermarkets, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Biopharmaceutical Logistic Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Biopharmaceutical Logistic Market by Transport Service Type
  • 6.1.3: Growth Opportunities for the Global Biopharmaceutical Logistic Market by End Use
  • 6.1.4: Growth Opportunities for the Global Biopharmaceutical Logistic Market by Region
• 6.2: Emerging Trends in the Global Biopharmaceutical Logistic Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Biopharmaceutical Logistic Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biopharmaceutical Logistic Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Kuehne + Nagel
• 7.2: C.H. Robinson
• 7.3: United Parcel Service
• 7.4: Deutsche Post DHL
• 7.5: Panalpina World Transport